N<SUP>4</SUP>-acetylcytidine of <i>Nop2</i> mRNA is required for the transition of morula-to-blastocyst

Mengyun Wang,Rui Cheng,Hongjuan He,Zhengbin Han,Yan Zhang,Qiong Wu
DOI: https://doi.org/10.1007/s00018-023-04955-w
IF: 8
2023-01-01
Cellular and Molecular Life Sciences
Abstract:N-acetyltransferase 10 (NAT10)-mediated N-4-acetylcytidine (ac(4)C) modification is crucial for mRNA stability and translation efficiency, yet the underlying function in mammalian preimplantation embryos remains unclear. Here, we characterized the ac(4)C modification landscape in mouse early embryos and found that the majority of embryos deficient in ac(4)C writer-NAT10 failed to develop into normal blastocysts. Through single-cell sequencing, RNA-seq, acetylated RNA immunoprecipitation combined with PCR (acRIP-PCR), and embryonic phenotype monitoring, Nop2 was screened as a target gene of Nat10. Mechanistically, Nat10 knockdown decreases the ac(4)C modification on Nop2 mRNA and reduces RNA and protein abundance by affecting the mRNA stability of Nop2. Then, depletion of NOP2 may inhibit the translation of transcription factor TEAD4, resulting in defective expression of the downstream lineage-specific gene Cdx2, and ultimately preventing blastomeres from undergoing the trophectoderm (TE) fate. However, exogenous Nop2 mRNA partially reverses this abnormal development. In conclusion, our findings demonstrate that defective ac(4)C modification of Nop2 mRNA hinders the morula-to-blastocyst transition by influencing the first cell fate decision in mice.
What problem does this paper attempt to address?